Previous reports have shown that blood lead levels in humans are associated with a polymorphic form of (5-aminolevulinate dehydratase (ALAD), an enzyme of heme biosynthesis that binds and is inhibited by lead. We hypothesized that ALAD levels may influence the distribution and accumulation of lead in the blood and target organs. To assess this, we studied strains of mice that differ in the numbers of copies of the ALAD gene. Our findings showed that mice with a duplication of the ALAD gene (DBA) accumulated twice the amount of lead in their blood and had higher lead levels in kidney and liver than mice with a single copy of the gene (C57) exposed to the same oral doses of lead during adulthood. Hybrid animals showed intermediate blood lead levels. Levels of blood zinc protoporphyrin (ZPP) increased with lead exposure in C57 animals while they were not affected in DBA mice, suggesting protection from production of this abnormal enzyme in mice with a duplication of the gene. Except for these protective effects in the formation of ZPP in DBA animals, duplication of the ALAD gene was found to increase lead accumulation. We conclude that although these mouse strains do not precisely replicate the polymorphism observed in humans, they may be used as a model to study genetic influences in lead bioaccumulation. Understanding genetic factors that affect susceptibility to lead-induced intoxication could have important implications for public health and intervention initiatives. These mouse strains may represent a useful model for future study of the role of ALAD in lead intoxication.
A Murine Model of Genetic Susceptibility to Lead Bioaccumulation. CLAUDIO, L., LEE, T., WOLFF, M. S., AND WETMUR, J. G. (1997) . Fundam. Appl. Toxicol. 35, [84] [85] [86] [87] [88] [89] [90] Previous reports have shown that blood lead levels in humans are associated with a polymorphic form of (5-aminolevulinate dehydratase (ALAD), an enzyme of heme biosynthesis that binds and is inhibited by lead. We hypothesized that ALAD levels may influence the distribution and accumulation of lead in the blood and target organs. To assess this, we studied strains of mice that differ in the numbers of copies of the ALAD gene. Our findings showed that mice with a duplication of the ALAD gene (DBA) accumulated twice the amount of lead in their blood and had higher lead levels in kidney and liver than mice with a single copy of the gene (C57) exposed to the same oral doses of lead during adulthood. Hybrid animals showed intermediate blood lead levels. Levels of blood zinc protoporphyrin (ZPP) increased with lead exposure in C57 animals while they were not affected in DBA mice, suggesting protection from production of this abnormal enzyme in mice with a duplication of the gene. Except for these protective effects in the formation of ZPP in DBA animals, duplication of the ALAD gene was found to increase lead accumulation. We conclude that although these mouse strains do not precisely replicate the polymorphism observed in humans, they may be used as a model to study genetic influences in lead bioaccumulation. Understanding genetic factors that affect susceptibility to lead-induced intoxication could have important implications for public health and intervention initiatives. These mouse strains may represent a useful model for future study of the role of ALAD in lead intoxication.
© 1997 Society of Toxicology.
Lead is a common environmental neurotoxin to which millions of people are exposed. It has been estimated that the number of children with blood lead levels above 15 fig/ dl in the United States may be between 3 and 4 million (U.S. Congress Office of Technology Assessment, 1990) . Lead intoxication also occurs in adults, most commonly in occupational settings (National Research Council, 1992) , and has been shown to produce deleterious neurological effects in adult humans (Schwartz et ai, 1993) . These figures translate into millions of dollars spent in direct medical cost expenditures, special education, and institutionalization costs, a reduction in productivity, and other costs to society. Lead 0272-0590/97 S25.OO 84 Copyright © 1997 by the Society of Toxicology. All rights of reproduction in any form reserved.
intoxication is one of the most serious and widespread environmentally induced ailments in the population of the United States, yet more needs to be learned about the mechanisms by which lead induces toxicity and about how lead may affect susceptible populations.
Various mechanisms for lead-induced neurotoxicity have been proposed. One such possible mechanism involves 6-aminolevulinate dehydratase (ALAD; porphobilinogen synthase; EC 4.2.1.24), the second enzyme in the heme biosynthetic pathway. This enzyme condenses two moles of deltaaminolevulinic acid to form porphobilinogen (for review see Beri and Chandra, 1993) . Decreases in ALAD activity have been shown to correlate with lead exposure in humans (Secchi et ai, 1974) and mice (Tomokuni et ai, 1991) . This polymorphic enzyme is coded by expression of two common alleles of the gene, which have been designated ALAD 1 and ALAD 2 . The ALAD 2 allele is the least common form, occurring at a frequency of 0.1 in the Caucasian population (Petrucci et ai, 1982; Benkman et ai, 1983) . It has been shown that adult workers with similar lead exposures who carry the ALAD 2 allele (1-2 and 2-2) accumulate more lead in their blood than individuals who do not carry this allele (1-1) (Wetmur et ai, 1991a; Wetmur, 1994) . This may be due to a higher affinity for lead in the ALAD 2 isozyme, which leads to higher levels of lead in the blood after exposure (Wetmur, 1994) . These data suggest that in humans there is a genetic susceptibility to lead intoxication; however, it is not known how these differences in affinity for lead in blood affect the tissue distribution of lead, its bioaccumulation, and its toxicity. The role of ALAD polymorphism in lead toxicity remains a difficult issue to address in epidemiological studies, although it would have important implications for public health initiatives (Schwartz et ai, 1995; Smith etai, 1995) .
To investigate the role of ALAD in lead bioaccumulation we used an experimental system consisting of two mouse strains which differ in the levels of hepatic ALAD enzyme activity (Doyle and Schimke, 1969; Hutton and Coleman, 1969) . It has been shown that DBA/2 mice have a two to three times greater dose of the ALAD gene than C57BL/6 mice and that this difference relates to the levels of enzyme activity in these mouse strains (Bishop et ai, 1986) . Hybrid animals (C57BL/6 X DBA/2) were found to have intermediate levels of enzyme activity in the same report. In the present study, we explore the possibility that these mouse strains may serve as a model for the differences in genetic susceptibility to lead accumulation observed in humans. We investigated the possibility that the ALAD genotype may affect the distribution and accumulation of lead.
METHODS

Animals.
Male and female C57BL/6J, DBA/2J, and hybrid mice (C57BL/6J X DBA/2J) of 6 to 8 weeks of age were purchased (Jackson Laboratories. Bar Harbor. ME) and housed two to four per cage in polycarbonate cages in the virus antibody-free facility of the Mount Sinai Center for Laboratory Animal Sciences. The animal facility was kept at 22 ± 2°C with a 12-hr light/dark cycle. Experiments were conducted in accordance with the Guiding Principles in the Use of Animals in Toxicology and with institutional guidelines for the ethical treatment of animals. Food (rodent chow) and water were provided ad libitum. Animals were given distilled drinking water for 1 week prior to lead exposure. During the lead exposure period, animals were housed individually in metabolism cages to facilitate urine collection. Lead acetate (Sigma, St. Louis, MO) was introduced into the drinking water at concentrations of 0, 250, 500, and 1000 ppm. Animals were exposed to lead acetate for 2 weeks, anesthetized with a mixture of ketamine/xylazine, and blood was collected by cardiac puncture into heparinized lead-free tubes. Hematocnt was measured immediately after blood collection Animals were then perfused with normal saline for 2 min and tissues were collected for further analysis.
Tissue analysis. All analyses were carried out in the Exposure Assessment Core Facility of the Mount Sinai Environmental Health Sciences Center, which participates in the Center for Disease Control Proficiency Testing Program. Zinc protoporphyrin was determined within 1 day of blood collection by hematofluorometry (Aviv Hematofluorometer, Model 206D, New Jersey). Blood lead levels were determined within 1 to 3 days of collection by atomic absorption spectrometry using a Perkin-Elmer 4100ZL spectrometer with a detection limit of 0.15 //g/dl. Determinations of lead in liver and kidney were performed using published methods (CorySlechta el al, 1989; Cory-Slechta, 1990 ). In brief, tissues were dissected, wet weights recorded, and then tissues were digested in a 1:1 mixture of nitric and perchloric acids in an oven at 110°C for 6 hr. The samples were brought to a constant volume with a mixture of nitric and hydrochloric acid, and then lead levels were determined by atomic absorption spectrometry. Urine lead levels were obtained using the same methods described above for atomic absorption spectrometry by an independent laboratory (Lead Tech, New Jersey).
Statistical analysis. The standard error of the mean was used in all graphs illustrating results from exposure groups. Student's t test was used to compare results between exposure groups and between strains to assess statistical significance. The exponential function was used to fit a curve to the data, illustrating the relationship between blood lead and zinc protoporphyrin levels for both strains.
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RESULTS
General Observations
Daily water intake for individual animals was measured in metabolism cages during the 14-day exposure period. The average water intake for all animals was 5.6 ± 0.5 ml/day and did not differ significantly among the groups. This suggested that lead acetate concentration in the drinking water 
Concentration of Lead in Drinking Water
FIG.
1. Blood lead levels for C57 and DBA male mice exposed to lead acetate in the drinking water for 14 days. All values for lead-exposed animals showed a statistically significant difference between exposure groups and between strains (p < 0.005). The values represent the means from 12 animals in each exposure group performed in 3 different experiments.
did not affect drinking behavior in the animals. Body weights were also measured before and after lead exposure was initiated. Before lead exposure was started, animals of both strains weighed an average of 19.5 ± 2.7 g. At the end of the exposure period, animals had gained an average of 2.2 ± 0.39 g and there were no significant differences between groups. This indicated that lead exposure did not affect food intake or the general health of the animals.
Blood Lead Levels
Blood lead levels were assessed in all experimental and control animals after the 14-day exposure period. All values were expressed as /xg/dl (unless otherwise indicated) and are shown in Fig. 1 . Student's t test showed that all values for the experimental groups were significantly different between exposure groups and between strains (p < 0.005). Control animals were not significantly different. Through this analysis we found that blood lead levels for DBA mice were approximately double the amounts determined for C57 mice exposed to the same concentrations of lead in the drinking water.
In a separate experiment, we determined the blood lead levels for C57, DBA, mice and hybrid mice denominated C57 X DBA. All animals were exposed to 500 ppm lead acetate in the drinking water for 14 days and all were 7 weeks old. For this experiment, half the animals in each group were female. These results are illustrated in Fig. 2 Blood lead levels for C57, DBA, and C57 X DBA mice exposed to 500 ppm lead acetate in the drinking water for 14 days. All animals were exposed during the same experiment and euthanized at the same time. Half of all animals in each group were male and half were female; all were the same age. Values were significantly different between groups (p < 0.05). C57 (n = 6); C57 X DBA (n = 12); DBA (n = 6).
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are plotted for individual animals in all exposure groups in Fig. 4 . These results indicate that for C57 mice, ZPP levels increased with increasing doses of lead acetate, while blood lead levels remained relatively low. The p value for the relationship between ZPP and blood lead in C57 animals was 0.001. For DBA animals the results were reversed: blood 125-C 'onlrol 250 ppm 500 ppm I (XX) ppm and show that hybrid mice had intermediate blood lead levels, values that fell between those found for C57 and DBA animals.
To assess possible gender differences in blood lead levels, male and female mice of both strains were exposed to lead acetate in the drinking water for 14 days (Fig. 3) . Blood lead levels for both genders were not significantly different in all dosage groups, except in animals exposed to 1000 ppm of lead acetate. In this group, female animals had higher blood lead levels than males in both strains (p < 0.05). To determine if these differences correlated with possible differences in levels of red blood cells, hematocrit readings were obtained. Hematocrit levels in these animals were slightly lower for females than for males, including controls, but this was not significantly different among the groups. These hematocrit values were 42.25% ± 1.7 for C57 females, 44.5% + 1.7 for C57 males, 39.5% + 2.0 for DBA females, and 42.5% + 1.7 for DBA males. Student's / test showed that hematocrit levels did not vary significantly with exposure to lead acetate in any of the groups.
Zinc Protoporphyrin (ZPP)
Since measurement of ZPP has been proposed as an indicator of recent lead intoxication (Blumberg et ai, 1984) , this parameter was analyzed in the two mouse strains and compared to blood lead levels in the same animals. The data Blood Lead Levels (ig/dL)
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FIG. 4.
Zinc protoporphyrin (ZPP) plotted against blood lead levels in C57 and DBA mice. Blood lead and ZPP levels were measured in C57 and DBA male mice exposed to 0, 250, 500, and 1000 ppm of lead acetate in the drinking water for 14 days. The data were plotted according to blood lead levels, regardless of oral dose for individual animals The results show that ZPP levels rise in C57 animals even when blood lead remained low, while for DBA animals exposed to the same amounts of lead, ZPP levels did not change significantly even when blood lead values were high C57 (n = 16); DBA (n = 16). lead levels increased with increasing lead dose while ZPP levels did not change significantly (p < 0.23). The results showed a striking difference in the mean levels of blood ZPP and blood lead for the two strains.
Lead Levels in Internal Organs
To assess how the difference in ALAD levels between the mouse strains affected the distribution of lead in the internal organs, levels of lead in kidney and liver were determined and compared to blood lead levels in the same animals. The animals were exposed to 0, 250, 500, and 1000 ppm lead acetate in the drinking water for 2 weeks as described above. Blood, kidney, and liver lead content were determined by atomic absorption spectrometry and the results are shown in Figs. 5A-5C. Both strains accumulated higher concentrations of lead in the kidneys than in the liver; however, in DBA animals these accumulations were much higher. Exposed to the same doses of lead, DBA animals accumulated an average of 4.1 times higher concentrations of lead in the liver and 2.4 times higher lead concentrations in the kidneys than C57 animals. The differences between exposure groups and between strains were statistically sig- 
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Dose (ppm) FIG. 6 . Lead concentrations in urine of C57 and DBA mice exposed to lead acetate in the drinking water for 14 days The data do not show statistically significant differences for lead excretion in urine between the strains. C57 (n = 16); DBA (n = 16). nificant at p < 0.005 (except for control animals). Blood lead levels in these experiments were 1.9 times higher in DBA than in mice of the C57 strain, consistent with values obtained in all other experiments.
Lead Excretion Studies
To assess the possibility that C57 animals may have higher excretion rates of lead than DBA animals, the concentrations of lead in urine were assessed daily for the animals (Fig. 6) . Mice of the C57 strain showed slightly higher concentrations of lead in urine than DBA animals; however, the values obtained did not show statistically significant differences between the strains. There was a high variability among the concentrations obtained within groups, especially for those animals exposed to the highest doses of lead.
DISCUSSION
Data previously obtained in our laboratories have shown that the presence of one or two copies of the ALAD 2 allele in humans correlates with blood lead levels that are approximately 10 fxg/d\ higher than those for individuals who do not carry this allele (Astrin et al., 1987; Wetmur et al., 1991a) . Furthermore, it has been estimated that nearly 40% of lead in blood is bound to ALAD (Wetmur, 1994) . These data suggested that ALAD 2 may be regarded as a lead susceptibility gene in humans, which can have important implications for public health (Wetmur et al., 1991b) . Based on these data, we hypothesized that the degree of ALAD activity in the blood may influence the bioaccumulation of lead in target organs. To further investigate this possibility, we have studied strains of mice which differ in the numbers of copies of the ALAD gene.
Our findings show that blood lead levels in DBA mice were approximately twice as high as the values obtained for C57 mice exposed to the same doses of lead in drinking water. These results were not due to differences in water intake or anemia. This possibility was a concern since it has been shown that a low blood iron status can increase lead absorption; conversely, it has also been proposed that lead can cause anemia (Eisinger, 1978; Schifman et al., 1982; Thunell et al., 1987) . In our experiments, intake of water containing lead and hematocrit measures did not show significant differences among the animals in any of our exposure protocols and thus did not produce an anemic state in the animals.
Another measure of the effects of lead in blood is the production of ZPP, which may be an indication of recent lead exposure (Blumberg et al., 1984) . The presence of lead in blood increases the production of ZPP through the inactivation of ferrochelase and the displacement of iron from protoporphyrin, causing its binding to zinc (Lamola and Yamane, 1974; Blumberg et al., 1984) . Since ZPP does not bind lead directly, lead may then be excreted, transported, and/or accumulated in tissues. It has been shown that increased ZPP is relatively harmless even in cases of serious lead intoxication because even in these cases ZPP-hemoglobin is less than 1% of the total hemoglobin produced (Blumberg et al., 1984) . In our experiments, ZPP measures increased with increasing lead exposure in C57 mice, suggesting that these animals were affected by exposure to lead even though their blood lead levels remained relatively low. This may be due to the lower amounts of ALAD in the blood of these animals, which would allow for lead unbound to ALAD to affect the production of ZPP. In the DBA mice the situation is reversed. The higher concentration of ALAD in the blood provides a high-affinity substrate for lead, reducing its effect on the production of ZPP.
We found that in DBA mice the concentrations of lead in kidney and liver were higher than those found in C57 mice given the same doses of lead. Since our measures of kidney and liver lead were done after thorough perfusion of animals with saline, we believe that the values obtained represent lead accumulations within the tissues examined, with minimal contribution from the circulating blood. These findings were not convincingly explained by differences in the urinary concentration of lead in these strains. This may not be surprising since excretion of lead is affected by many factors and thus is not considered a good measure of lead exposure in mice (Regoli and Orlando, 1994) Health Organization, 1977). These results suggest that although higher blood ALAD levels may be protective against the production of blood ZPP in animals with a duplication of the gene, this duplication may increase the accumulation of lead in the tissues of internal organs.
Although this mouse model differs from the human situation in that it involves a gene duplication rather than a polymorphism, we have used it here to determine the role of ALAD concentrations on the distribution of lead to organ tissues. We have found that the mouse model parallels the human findings in that DBA mice, which have a duplication of the ALAD gene, showed blood lead levels that were twice the values obtained for C57 mice that have only one copy of the ALAD gene. Our results on hybrid (C57 X DBA) mice further support the conclusion that blood lead levels are related to ALAD concentrations in these mice. However, further investigations using back-crossed animals are underway in order to confirm these findings. Mouse strains C57BL/6J and DBA/2J do not only differ in ALAD gene locus. Some of the other differences that have been found in these animals are their susceptibility to cancer-causing agents (Ahotupa et al., 1993; Rebuffe-Scrive et al., 1993; Gonzalez, 1995) , performance in learning tasks (AmmassariTeule et al., 1993; Fordyce and Wehner, 1993; Bentivoglio et al., 1994) , susceptibility to epileptic seizures (Esplin et al., 1994) , and susceptibility to hearing loss with age (Willott et al., 1994) . To address this limitation, we are in the process of constructing transgenic mice with the human genes.
Nevertheless, in the present study we have found significant differences in the accumulation of lead in blood, kidney, and liver of mice with a duplication of the ALAD gene compared with mice with single copies of the gene exposed to the same doses. These results were reproducible since the strains of mice used in the study are well defined and commercially available. We conclude that the C57BL/6J and DBA/2J mouse strains can serve as useful models for the study of genetic susceptibility to lead bioaccumulation at least until better models of the human become available.
